By Lauran Neergaard The Associated Press Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 06/Nov 05:52
In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, estrogen receptor-positive (ER+) breast cancer and were able to shrink tumors, reduce the number of cancer stem cells and reprogram the immune environment to be less supportive of cancer growth.
By Lauran Neergaard The Associated Press Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But...
By Lauran Neergaard The Associated Press Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But...
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation.
Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...
Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...
In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival,...
A new study led by researchers at UCLA Health has given doctors and patients clearer guidance on how long hormone therapy, known as androgen...
A new study led by researchers at UCLA Health has given doctors and patients clearer guidance on how long hormone therapy, known as androgen...
Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic,...
Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic,...